Literature DB >> 9207067

Vascular endothelial growth factor: crystal structure and functional mapping of the kinase domain receptor binding site.

Y A Muller1, B Li, H W Christinger, J A Wells, B C Cunningham, A M de Vos.   

Abstract

Vascular endothelial growth factor (VEGF) is a homodimeric member of the cystine knot family of growth factors, with limited sequence homology to platelet-derived growth factor (PDGF) and transforming growth factor beta2 (TGF-beta). We have determined its crystal structure at a resolution of 2.5 A, and identified its kinase domain receptor (KDR) binding site using mutational analysis. Overall, the VEGF monomer resembles that of PDGF, but its N-terminal segment is helical rather than extended. The dimerization mode of VEGF is similar to that of PDGF and very different from that of TGF-beta. Mutational analysis of VEGF reveals that symmetrical binding sites for KDR are located at each pole of the VEGF homodimer. Each site contains two functional "hot spots" composed of binding determinants presented across the subunit interface. The two most important determinants are located within the largest hot spot on a short, three-stranded sheet that is conserved in PDGF and TGF-beta. Functional analysis of the binding epitopes for two receptor-blocking antibodies reveal different binding determinants near each of the KDR binding hot spots.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9207067      PMCID: PMC23789          DOI: 10.1073/pnas.94.14.7192

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  Improved methods for building protein models in electron density maps and the location of errors in these models.

Authors:  T A Jones; J Y Zou; S W Cowan; M Kjeldgaard
Journal:  Acta Crystallogr A       Date:  1991-03-01       Impact factor: 2.290

2.  Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons.

Authors:  A Nicholls; K A Sharp; B Honig
Journal:  Proteins       Date:  1991

3.  Comparison of a structural and a functional epitope.

Authors:  B C Cunningham; J A Wells
Journal:  J Mol Biol       Date:  1993-12-05       Impact factor: 5.469

4.  Crystal structure of a complex between interferon-gamma and its soluble high-affinity receptor.

Authors:  M R Walter; W T Windsor; T L Nagabhushan; D J Lundell; C A Lunn; P J Zauodny; S K Narula
Journal:  Nature       Date:  1995-07-20       Impact factor: 49.962

Review 5.  A structural superfamily of growth factors containing a cystine knot motif.

Authors:  N Q McDonald; W A Hendrickson
Journal:  Cell       Date:  1993-05-07       Impact factor: 41.582

6.  Nerve growth factor in different crystal forms displays structural flexibility and reveals zinc binding sites.

Authors:  D R Holland; L S Cousens; W Meng; B W Matthews
Journal:  J Mol Biol       Date:  1994-06-10       Impact factor: 5.469

7.  New protein fold revealed by a 2.3-A resolution crystal structure of nerve growth factor.

Authors:  N Q McDonald; R Lapatto; J Murray-Rust; J Gunning; A Wlodawer; T L Blundell
Journal:  Nature       Date:  1991-12-05       Impact factor: 49.962

Review 8.  Angiogenesis in cancer, vascular, rheumatoid and other disease.

Authors:  J Folkman
Journal:  Nat Med       Date:  1995-01       Impact factor: 53.440

Review 9.  Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis.

Authors:  H F Dvorak; L F Brown; M Detmar; A M Dvorak
Journal:  Am J Pathol       Date:  1995-05       Impact factor: 4.307

10.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

Authors:  L P Aiello; R L Avery; P G Arrigg; B A Keyt; H D Jampel; S T Shah; L R Pasquale; H Thieme; M A Iwamoto; J E Park
Journal:  N Engl J Med       Date:  1994-12-01       Impact factor: 91.245

View more
  95 in total

1.  Evolution of the VEGF-regulated vascular network from a neural guidance system.

Authors:  Sreenivasan Ponnambalam; Mario Alberghina
Journal:  Mol Neurobiol       Date:  2011-01-28       Impact factor: 5.590

2.  Extending foldamer design beyond α-helix mimicry: α/β-peptide inhibitors of vascular endothelial growth factor signaling.

Authors:  Holly S Haase; Kimberly J Peterson-Kaufman; Sheeny K Lan Levengood; James W Checco; William L Murphy; Samuel H Gellman
Journal:  J Am Chem Soc       Date:  2012-05-01       Impact factor: 15.419

3.  Vascular endothelial growth factor A (VEGF-A) induces endothelial and cancer cell migration through direct binding to integrin {alpha}9{beta}1: identification of a specific {alpha}9{beta}1 binding site.

Authors:  Saji Oommen; Shiv K Gupta; Nicholas E Vlahakis
Journal:  J Biol Chem       Date:  2010-11-11       Impact factor: 5.157

4.  Identification of specific molecular structures of human immunodeficiency virus type 1 Tat relevant for its biological effects on vascular endothelial cells.

Authors:  S Mitola; R Soldi; I Zanon; L Barra; M I Gutierrez; B Berkhout; M Giacca; F Bussolino
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

5.  Targeting angiogenesis: structural characterization and biological properties of a de novo engineered VEGF mimicking peptide.

Authors:  Luca Domenico D'Andrea; Guido Iaccarino; Roberto Fattorusso; Daniela Sorriento; Concetta Carannante; Domenica Capasso; Bruno Trimarco; Carlo Pedone
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-26       Impact factor: 11.205

6.  Design, synthesis, and evaluation of original carriers for targeting vascular endothelial growth factor receptor interactions.

Authors:  Mario Gonçalves; Karine Estieu-Gionnet; Thomas Berthelot; Georges Laïn; Mireille Bayle; Xavier Canron; Natacha Betz; Andreas Bikfalvi; Gérard Déléris
Journal:  Pharm Res       Date:  2005-08-03       Impact factor: 4.200

7.  In vitro and in vivo release of vascular endothelial growth factor from gelatin microparticles and biodegradable composite scaffolds.

Authors:  Zarana S Patel; Hiroki Ueda; Masaya Yamamoto; Yasuhiko Tabata; Antonios G Mikos
Journal:  Pharm Res       Date:  2008-07-29       Impact factor: 4.200

8.  SUN11602, a novel aniline compound, mimics the neuroprotective mechanisms of basic fibroblast growth factor.

Authors:  Norihito Murayama; Taisuke Kadoshima; Naohiro Takemoto; Shiho Kodama; Tetsuya Toba; Ryoko Ogino; Takafumi Noshita; Tetsushi Oka; Shinya Ueno; Mariko Kuroda; Yoshiari Shimmyo; Yasuhiro Morita; Teruyoshi Inoue
Journal:  ACS Chem Neurosci       Date:  2012-11-21       Impact factor: 4.418

9.  Lutropins appear to contact two independent sites in the extracellular domain of their receptors.

Authors:  M P Bernard; R V Myers; W R Moyle
Journal:  Biochem J       Date:  1998-11-01       Impact factor: 3.857

10.  Activated forms of VEGF-C and VEGF-D provide improved vascular function in skeletal muscle.

Authors:  Andrey Anisimov; Annamari Alitalo; Petra Korpisalo; Jarkko Soronen; Seppo Kaijalainen; Veli-Matti Leppänen; Michael Jeltsch; Seppo Ylä-Herttuala; Kari Alitalo
Journal:  Circ Res       Date:  2009-05-14       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.